Methenamine borate tablets

Hazard statements (CLP)

H228, H317, H319, H360FD

Code

Statements

H228

Flammable solid

SECTION 2: Hazards identification

2.1 Classification of the substance or mixture

Flammable solids, (Category 2) H228: Flammable solid. Eye irritation, (Category 2) H319: Causes serious eye irritation. Skin sensitization, (Category 1) H317: May cause an allergic skin reaction. Reproductive toxicity, (Category H360FD: May damage fertility. May 1B) damage the unborn child.

2.2 Label elements

Labelling

Signal word

Danger Danger

Hazard statements

H228 Flammable solid. H317 May cause an allergic skin reaction. H319 Causes serious eye irritation. H360FD May damage fertility. May damage the unborn child. Restricted to professional users. Reduced Labeling (<= 125 ml) H317 May cause an allergic skin reaction. H360FD May damage fertility. May damage the unborn child.

Precautionary statements

P202 Do not handle until all safety precautions have been read and understood. P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 IF ON SKIN: Wash with plenty of water. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P302 + P352 IF ON SKIN: Wash with plenty of water. P308 + P313 IF exposed or concerned: Get medical advice/ attention.

Supplemental label elements

none none

2.3 Other hazards

This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

ECOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.

TOXICOLOGICAL INFORMATION

The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.